Interpretation of Chinese expert consensus on surgical treatment of infective endocarditis
-
摘要: 外科手术是感染性心内膜炎(IE)的主要治疗方式之一，但IE相关瓣膜手术风险居所有心脏瓣膜手术首位，且在中国诊疗同质性较差。2022年3月，中华医学会胸心血管外科分会发布了《感染性心内膜炎外科治疗中国专家共识》，主要围绕IE诊断标准、手术指征及时机、术前评估及管理、手术策略、术后管理及随访、特殊类型IE诊疗等内容达成共识。为了更好地理解专家共识、促进IE外科诊疗规范，本文将对其核心内容进行解读。Abstract: Cardiac surgical procedure is the preferred treatment modality for infective endocarditis(IE). However, the risk of IE-related valve surgery ranks first among all valve surgeries, and the level of diagnosis and treatment varies greatly. In March 2022, Chinese Society for Thoracic and Cardiovascular Surgery issued the "Chinese Expert Consensus on Surgical Treatment of Infectious Endocarditis", which mainly focuses on IE diagnostic criteria, surgical indications and timing, preoperative evaluation and management, surgical strategies, postoperative management and follow-up, diagnosis and treatment of special types of IE. In order to better understand the expert consensus and standardize the surgical diagnosis and treatment of IE, this paper interprets its core contents.
-
Key words:
- infective endocarditis /
- cardiac surgical procedure /
- expert consensus /
- interpretation
-
-
[1] 中华医学会胸心血管外科分会瓣膜病外科学组. 感染性心内膜炎外科治疗中国专家共识[J]. 中华胸心血管外科杂志, 2022, 38(3): 146-155.
[2] Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2021, 143(5): e35-e71.
[3] Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J, 2022, 43(7): 561-632. doi: 10.1093/eurheartj/ehab395
[4] 成人感染性心内膜炎预防、诊断和治疗专家共识[J]. 实用心脑肺血管病杂志, 2016, 24(10): 106.
[5] Cooper HA, Thompson EC, Laureno R, et al. Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses(EMBOLISM)pilot study[J]. Circulation, 2009, 120(7): 585-591. doi: 10.1161/CIRCULATIONAHA.108.834432
[6] Byrne JG, Rezai K, Sanchez JA, et al. Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline[J]. Ann Thoracic Surg, 2011, 91(6): 2012-2019. doi: 10.1016/j.athoracsur.2011.01.106
[7] Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association[J]. Circulation, 2015, 132(15): 1435-1486. doi: 10.1161/CIR.0000000000000296
[8] Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2015, 36(44): 3075-3128. doi: 10.1093/eurheartj/ehv319
[9] Pettersson GB, Coselli JS, Writing Committee, et al. 2016 The American Association for Thoracic Surgery(AATS)consensus guidelines: surgical treatment of infective endocarditis: Executive summary[J]. J Thorac Cardiovasc Surg, 2017, 153(6): 1241-1258.e29. doi: 10.1016/j.jtcvs.2016.09.093
[10] Toyoda N, Itagaki S, Egorova NN, et al. Real-world outcomes of surgery for native mitral valve endocarditis[J]. J Thorac Cardiovasc Surg, 2017, 154(6): 1906-1912.e9. doi: 10.1016/j.jtcvs.2017.07.077
[11] Lee HA, Cheng YT, Wu VC, et al. Nationwide cohort study of mitral valve repair versus replacement for infective endocarditis[J]. J Thorac Cardiovasc Surg, 2018, 156(4): 1473-1483.e2. doi: 10.1016/j.jtcvs.2018.04.064
[12] Harky A, Hof A, Garner M, et al. Mitral valve repair or replacement in native valve endocarditis? Systematic review and meta-analysis[J]. J Card Surg, 2018, 33(7): 364-371. doi: 10.1111/jocs.13728
[13] de Kerchove L, Vanoverschelde JL, Poncelet A, et al. Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability[J]. Eur J Cardiothorac Surg, 2007, 31(4): 592-599. doi: 10.1016/j.ejcts.2007.01.002
[14] Hussain ST, Shrestha NK, Gordon SM, et al. Residual patient, anatomic, and surgical obstacles in treating active left-sided infective endocarditis[J]. J Thorac Cardiovasc Surg, 2014, 148(3): 981-988.e4. doi: 10.1016/j.jtcvs.2014.06.019
[15] Anantha-Narayanan M, Reddy Y, Sundaram V, et al. Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis[J]. Heart, 2020, 106(18): 1413-1419. doi: 10.1136/heartjnl-2020-316718
[16] Harding D, Cahill TJ, Redwood SR, et al. Infective endocarditis complicating transcatheter aortic valve implantation[J]. Heart, 2020, 106(7): 493-498. doi: 10.1136/heartjnl-2019-315338
[17] Khan A, Aslam A, Satti KN, et al. Infective endocarditis post-transcatheter aortic valve implantation(TAVI), microbiological profile and clinical outcomes: A systematic review[J]. PLoS One, 2020, 15(1): e0225077. doi: 10.1371/journal.pone.0225077
[18] Monteagudo Ruiz JM, Zamorano Gómez JL. Endocarditis after transcatheter aortic valve implantation: a new fiend we hardly know[J]. Eur Heart J, 2019, 40(39): 3270-3272. doi: 10.1093/eurheartj/ehz734
-
计量
- 文章访问数: 2135
- PDF下载数: 2103
- 施引文献: 0
下载: